We also confirmed these in vivo findings in HEK293T (Figure 1f,g) and HT22 mouse neuroblastoma cells (Figure 1h,i) transfected with GFP-Parkin + CHCHD10 variants and treated with the mitochondrial uncoupler CCCP, where similar results were observed in both Western blotting (Figure 1f,g) and immunocytochemistry (ICC) (Figure 1h,i), respectively. This evidence concerns the gene PRKN and neuroblastoma.